Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Neuropsychological outcome in refractory obsessive-compulsive disorder treated with anterior capsulotomy including repeated surgery

L. Krámská, D. Urgošík, R. Liščák, L. Hrešková, J. Skopová

. 2021 ; 75 (3) : 101-107. [pub] 20210120

Language English Country Australia

Document type Journal Article

Grant support
IG 161201 Ministerstvo Zdravotnictví Ceske Republiky

E-resources Online Full text

NLK Free Medical Journals from 1997 to 2 years ago
Medline Complete (EBSCOhost) from 1998-02-01 to 1 year ago
Wiley Free Content from 1997 to 1 year ago

AIM: Anterior capsulotomy (AC) is one of the last therapeutic options for obsessive-compulsive disorder (OCD) refractory to conservative treatments. Several forms of cognitive dysfunction have been identified after assessment of neuropsychological outcomes in OCD patients; however, few studies focused on cognitive changes in OCD patients after surgery. In the present study, we evaluated the effects of AC on cognitive performance and mood status in patients with refractory OCD. METHODS: A total of 12 patients underwent bilateral AC between 2012 and 2019 at our institution. The patients (n = 12, female : male 5:7; mean age 39.7 years; duration ≥5 years) were assessed before and 6 months after intervention. The diagnosis of treatment-refractory OCD was based on recommended criteria for surgical treatment. Patients were assessed using a neuropsychological battery and questionnaires focused on anxiety-depressive symptomatology. The Yale-Brown Obsessive Compulsive Scale was administered as a measure of severity of OCD symptoms. RESULTS: We detected a significant decrease of OCD, and anxiety and depressive symptomatology assessed by Yale-Brown Obsessive Compulsive Scale, Beck Depression Inventory, and Beck Anxiety Inventory (P < 0.05) 6 months after AC in eight patients, and a partial decrease in four patients. Four patients underwent repeated AC with more pronounced improvement achieved after the first procedure. We did not detect decline in cognitive performance in any patients, but did find better visual memory performance (P < 0.05). CONCLUSION: AC reduced OCD and anxiety-depressive symptoms, and did not appear to influence cognitive performance, even after repeated surgery.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004598
003      
CZ-PrNML
005      
20220127145126.0
007      
ta
008      
220113s2021 at f 000 0|eng||
009      
AR
024    7_
$a 10.1111/pcn.13190 $2 doi
035    __
$a (PubMed)33368824
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a at
100    1_
$a Krámská, Lenka $u Department of Clinical Psychology, Na Homolce Hospital, Prague, Czech Republic $u Department of Neurology, Na Homolce Hospital, Prague, Czech Republic $u Charles University in Prague, Prague, Czech Republic
245    10
$a Neuropsychological outcome in refractory obsessive-compulsive disorder treated with anterior capsulotomy including repeated surgery / $c L. Krámská, D. Urgošík, R. Liščák, L. Hrešková, J. Skopová
520    9_
$a AIM: Anterior capsulotomy (AC) is one of the last therapeutic options for obsessive-compulsive disorder (OCD) refractory to conservative treatments. Several forms of cognitive dysfunction have been identified after assessment of neuropsychological outcomes in OCD patients; however, few studies focused on cognitive changes in OCD patients after surgery. In the present study, we evaluated the effects of AC on cognitive performance and mood status in patients with refractory OCD. METHODS: A total of 12 patients underwent bilateral AC between 2012 and 2019 at our institution. The patients (n = 12, female : male 5:7; mean age 39.7 years; duration ≥5 years) were assessed before and 6 months after intervention. The diagnosis of treatment-refractory OCD was based on recommended criteria for surgical treatment. Patients were assessed using a neuropsychological battery and questionnaires focused on anxiety-depressive symptomatology. The Yale-Brown Obsessive Compulsive Scale was administered as a measure of severity of OCD symptoms. RESULTS: We detected a significant decrease of OCD, and anxiety and depressive symptomatology assessed by Yale-Brown Obsessive Compulsive Scale, Beck Depression Inventory, and Beck Anxiety Inventory (P < 0.05) 6 months after AC in eight patients, and a partial decrease in four patients. Four patients underwent repeated AC with more pronounced improvement achieved after the first procedure. We did not detect decline in cognitive performance in any patients, but did find better visual memory performance (P < 0.05). CONCLUSION: AC reduced OCD and anxiety-depressive symptoms, and did not appear to influence cognitive performance, even after repeated surgery.
650    _2
$a dospělí $7 D000328
650    _2
$a úzkost $x terapie $7 D001007
650    _2
$a deprese $x terapie $7 D003863
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a capsula interna $x chirurgie $7 D020772
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a neuropsychologické testy $7 D009483
650    12
$a neurochirurgické výkony $x škodlivé účinky $7 D019635
650    _2
$a obsedantně kompulzivní porucha $x chirurgie $7 D009771
650    12
$a hodnocení výsledků zdravotní péče $7 D017063
650    12
$a pooperační kognitivní dysfunkce $x etiologie $7 D000079690
650    12
$a reoperace $x škodlivé účinky $7 D012086
655    _2
$a časopisecké články $7 D016428
700    1_
$a Urgošík, Dušan $u Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Liščák, Roman $u Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Hrešková, Lucia $u Department of Clinical Psychology, Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Skopová, Jaroslava $u Department of Psychiatry, Na Homolce Hospital, Prague, Czech Republic
773    0_
$w MED00007217 $t Psychiatry and clinical neurosciences $x 1440-1819 $g Roč. 75, č. 3 (2021), s. 101-107
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33368824 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145122 $b ABA008
999    __
$a ok $b bmc $g 1751912 $s 1155747
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 75 $c 3 $d 101-107 $e 20210120 $i 1440-1819 $m Psychiatry and clinical neurosciences $n Psychiatry Clin Neurosci $x MED00007217
GRA    __
$a IG 161201 $p Ministerstvo Zdravotnictví Ceske Republiky
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...